The one-electron reduction of redox-active chemotherapeutic agents generates highly toxic radical anions and reactive oxygen intermediates (ROI). A major enzyme catalyzing this process is cytochrome P450 reductase. Because many tumor cells highly express this enzyme, redox cycling of chemotherapeutic agents in these cells may confer selective antitumor activity. Nitrofurantoin is a commonly used redox-active antibiotic that possesses antitumor activity. In the present studies we determined whether nitrofurantoin redox cycling is correlated with cytochrome P450 reductase activity and cytotoxicity in a variety of cell lines. Recombinant cytochrome P450 reductase was found to support redox cycling of nitrofurantoin and to generate superoxide anion, hydrogen peroxide, and, in the presence of redox-active iron, hydroxyl radicals. This activity was NADPH dependent and inhibitable by diphenyleneiodonium, indicating a requirement for the flavin cofactors in the reductase. Nitrofurantoin-induced redox cycling was next analyzed in different cell lines varying in cytochrome P450 reductase activity including Chinese hamster ovary cells (CHO-OR) constructed to overexpress the enzyme. Nitrofurantoin-induced hydrogen peroxide production was 16-fold greater in lysates from CHO-OR cells than from control CHO cells. A strong correlation between cytochrome P450 reductase activity and nitrofurantoin-induced redox cycling among the cell lines was found. Unexpectedly, no correlation between nitrofurantoininduced ROI production and cytotoxicity was observed. These data indicate that nitrofurantoininduced redox cycling and subsequent generation of ROI are not sufficient to mediate cytotoxicity and that cytochrome P450 reductase is not a determinant of sensitivity to redox-active chemotherapeutic agents.
Introduction
Murine lung epithelial cells (MLE 15 cells) were obtained from Dr. Jacob N. Finkelstein at the University of Rochester, NY. All other cell lines were purchased from the American Type Culture Collection (Rockville, MD). CHO-WT, CHO-OR, and PC-3 cells were maintained in Ham's F12K medium. MLE 15, RAW 264.7, C2, S-180, B16, HL-60, HT-29, and HeLa cells were maintained in Dulbecco's modified Eagle's medium. All medium was supplemented with 10% fetal bovine serum, penicillin (100 units/ml), and streptomycin (100 μg/ml). For CHO cells, the medium was also supplemented with 500 μg/ml hygromycin B (Invitrogen, Carlsbad, CA). Cells were incubated at 37 °C in 5% CO 2 in a humidified incubator. Tissue culture reagents were from Gibco BRL (Grand Island, NY). C2 cells are a continuously grown mouse muscle cell line, while MLE 15 cells are a continuously grown type II lung cell line isolated from SV40 large tumor antigen transgenic mice [16] .
To prepare lysates, cells were scraped from culture dishes in phosphate-buffered saline (PBS), washed, and centrifuged (800g, 5 min). Cell pellets were stored at -70 °C until analysis. Before enzyme assays, cell pellets were resuspended in PBS (~10 7 cells/0.5 ml) and sonicated on ice using a sonic dismembrator (Artek Systems Inc., Farmingdale, NY). Homogenates were then sequentially centrifuged at 4 °C (3000g and 12,000g, for removal of cellular debris and mitochondrial fractions, respectively). The resulting supernatant fractions were used in enzyme assays. Protein concentrations were quantified using the Dc protein assay kit (Bio-Rad, Hercules, CA) with bovine serum albumin as the standard.
Cell growth inhibition was evaluated as previously described [17] . Briefly, cells were plated at low density (2.5-10 × 10 4 cells/well) in six-well tissue culture plates and allowed to adhere overnight. The medium was then replaced with growth medium supplemented with increasing concentrations of nitrofurantoin. After 4-5 days, cells were removed from the plates and counted using a Z1 Coulter Particle Counter (Beckman Coulter, Hialeah, FL). Concentrations of nitrofurantoin that caused 50% growth inhibition (IC 50 ) were then determined.
Kinetic analysis of H 2 O 2 production
H 2 O 2 production was measured using the Amplex red/horseradish peroxidase method [18] . Standard reaction mixes in 100 μl potassium phosphate buffer (50 mM, pH 7.4) contained 0-0.5 mM NADPH, 0-500 μM nitrofurantoin, 25 μM Amplex red, 1 unit/ml horseradish peroxidase, and 1.25 μg/ml cytochrome P450 reductase or 100 μg/ml cell protein. The fluorescent product resorufin was detected using an HTS 7000 Plus Bio Assay Reader (Perkin-Elmer Life Sciences, Shelton, CT) using a 540-nm excitation filter and a 595-nm emission filter. Increases in fluorescence intensity were measured every 2.5 min for 30 min at 37 °C. H 2 O 2 production is formed via the one-electron reduction of nitrofurantoin by cytochrome P450 reductase, the interaction of reduced nitrofurantoin with oxygen producing the parent compound and superoxide, and the dismutation of superoxide to hydrogen peroxide. Because the last two steps proceed at very high rates [19] , we assumed that the measurement of K m and V max reflect the one-electron enzymatic reaction.
Assays for hydroxyl radical and superoxide anion
The generation of 2-hydroxyterephthalate from terephthalate in enzyme assays was used as an indicator of hydroxyl radical production [20] . Standard reaction mixes in 0.2 ml potassium phosphate buffer (50 mM, pH 7.4) contained 6.25 μg/ml cytochrome P450 reductase or 150 μg/ml cell protein from supernatant fractions, 1 mM terephthalate, 0.5 mM NADPH. Reactions were initiated by the addition of Fe 3+ /EDTA (100 μM/110 μM) to the assay mixture. After incubation at 37 °C for 1 h, reactions were stopped by adding an equal volume of ice-cold methanol. 2-Hydroxyterephthalate was quantified by HPLC with fluorescence detection as previously described [20] .
Superoxide anion was assayed by the formation of 2-hydroxyethidium from dihydroethidium [21] . Standard reaction mixes described above were used except that Fe 3+ / EDTA was omitted and dihydroethidium (40 μM) was used in place of terephthalate. 2-Hydroxyethidium was detected using a Shimadzu HPLC (Kyoto, Japan) fitted with a Luna C18 column (250 mm × 2.0 mm; Phenomenex, Torrance, CA) and a fluorescence detector with excitation and emission wavelengths set at 510 and 595 nm, respectively. The mobile phase consisted of a linear (10-40%) gradient of acetonitrile in 0.1% trifluoroacetic acid and was run at a flow rate of 0.2 ml/min in 35 min.
Assay for NADPH metabolism
NADPH metabolism was assayed in reaction mixes containing 100 μM NADPH, 7.5 μg/ml cytochrome P450 reductase, with or without 50 μM nitrofurantoin in 1 ml potassium phosphate buffer (50 mM, pH 7.4). Depletion of NADPH in reaction mixes was quantified by decreases in absorbance at 340 nm using a Lambda 20 UV/VIS spectrometer (PerkinElmer Life Sciences), scanning at 1 nm/s and recording at 1-nm intervals, repeating the scan in 2.5-min intervals for 25 min.
Cytochrome c reduction assay
A cytochrome c reductase (NADPH) assay kit (Sigma-Aldrich) was used to assess enzyme activity. The assay was performed in a 1.1-ml final reaction volume containing 31 μM cytochrome c in 300 mM potassium phosphate buffer (pH 7.8), 50 μl cell protein from supernatant fractions, and 0-500 μM nitrofurantoin. The reaction was initiated by the addition of 100 μl NADPH (final concentration, 100 μM). Increases in absorbance at 550 nm were monitored spectrophotometrically. Enzyme activity was expressed as units/mg protein; one unit is defined as 1 nmol cytochrome c reduced per min. In this assay, nitrofurantoin did not alter cytochrome P450 reductase-mediated reduction rates of cytochrome c.
Measurement of ROI in intact cells
Intracellular ROI were quantified using DCFH-DA in conjunction with flow cytometry as previously described [22] . In brief, cells were suspended in PBS (1 × 10 6 /ml) and incubated with 5 μM DCFH-DA at 37 °C in a shaking water bath for 15 min. Nitrofurantoin was then added. After 3 h, cellular fluorescence was analyzed using a Cytomics FC 500 flow cytometer (Beckman Coulter, Fullerton, CA). Data were analyzed by CXP software (Beckman Coulter).
Statistical analysis
Each determination was done in duplicate or triplicate and repeated two or three times. Differences were analyzed for statistical significance using the one-way ANOVA or unpaired t test with GraphPad Instat software. p < 0.05 was considered significant.
Results

Nitrofurantoin induces redox cycling via cytochrome P450 reductase
Initially, an H 2 O 2-generating system with cDNA-expressed rat cytochrome P450 reductase was used to characterize the ability of nitrofurantoin to redox cycle. Constitutive level of H 2 O 2 generation without nitrofurantoin was detected in the reaction mix ( Fig. 2A) . The addition of nitrofurantoin increased H 2 O 2 production in concentration-dependent manner. The K m and V max for nitrofurantoin in the reaction with cytochrome P450 reductase were 318.3 ± 67.9 μM and 650.7 ± 95.8 nmol H 2 O 2 /mg protein/min, respectively ( Table 1 ). The reaction was dependent on NADPH which is utilized during the enzyme reaction (Fig. 3) . Nitrofurantoin was found to increase the V max for NADPH utilization by cytochrome P450 reductase. With 100 μM nitrofurantoin, the V max for NADPH increased approximately nine fold, with no major changes in its K m (p = 0.32; Table 2 ). The flavoproteins inhibitor diphenyleneiodonium inhibited nitrofurantoin-induced H 2 O 2 generation (IC 50 = 0.2 μM) (Fig. 4) . In contrast, no effects on this reaction were observed with potassium cyanide (0.1-30 μM), an inhibitor of respiratory oxidoreductases, dicoumarol (0.1-100 μM), an NAD(P)H: quinone oxidoreductase 1 (NQO1) inhibitor, or L-NAME (0.1-100 μM), a nitric oxide synthase inhibitor.
Nitrofurantoin also stimulated superoxide anion and hydroxyl radical production supported by cytochrome P450 reductase (Figs. 2B and 2C). As noted for H 2 O 2 , constitutive levels of these ROI were detectable in control reactions. Increases in superoxide anion (p < 0.05) and hydroxyl radical (p < 0.01) generation in the presence of nitrofurantoin were time and concentration dependent (Figs. 2B and 2C). Whereas superoxide dismutase (SOD) inhibited the formation of superoxide (p < 0.05) (Fig. 2C ), hydroxyl radicals were abolished by catalase (p < 0.01) and by DMSO (p < 0.05) (Fig. 2B ). Production of hydroxyl radicals was dependent on iron, a finding consistent with the ability of nitrofurantoin to generate H 2 O 2 during redox cycling, and its subsequent conversion to hydroxyl radicals via the Fenton reaction [23] . As observed with H 2 O 2 production, diphenyleneiodonium also inhibited cytochrome-P450-reductase-mediated production of superoxide and hydroxyl radicals (data not shown).
In our next series of experiments, we compared nitrofurantoin redox cycling in CHO cells with stable expression of cytochrome P450 reductase (CHO-OR) and wild-type cells (CHO-WT). CHO-OR cells express 30-fold more cytochrome P450 reductase activity, as measured by cytochrome c reduction, than CHO-WT cells [15] . In the absence of nitrofurantoin, constitutive levels of H 2 O 2 were generated by both cell types. CHO-OR cells produced approximately 2-to 3-fold more H 2 O 2 than CHO-WT cells (p = 0.01; Figs. 5A and 5B). Nitrofurantoin caused a concentration-dependent increase in H 2 O 2 production in enzyme preparations from both cell types (Figs. 5A and 5B). Significantly greater activity was detected in CHO-OR cells overexpressing cytochrome P450 reductase. The nitrofurantoinstimulated V max for H 2 O 2 production in lysates from cytochrome-P450-reductaseoverexpressing cells was approximately 16-fold greater than that in wild-type cells (32.9 ± 4.8 nmol H 2 O 2 /mg protein/min vs 2.1 ± 0.4 nmol H 2 O 2 /mg protein/min, respectively). No major differences in the K m values for nitrofurantoin in the two cell types were observed (p = 0.36; Table 1 ). In contrast to the kinetic constants for recombinant cytochrome P450 reductase, nitrofurantoin increased both the K m for NADPH and the V max for the generation of H 2 O 2 in the CHO cells. Thus, in the presence of 100 μM nitrofurantoin, the K m for NADPH increased about 1.5-fold in CHO-WT cells and more than 9-fold in CHO-OR cells whereas the V max increased 4-fold in CHO-WT cells and 40-fold in CHO-OR cells (Table   2 ).
Constitutive production of superoxide anion and hydroxyl radicals was also detected in CHO cells (Figs. 5C and 5D ). CHO-OR cells produced greater amounts of hydroxyl radicals than CHO-WT cells (p < 0.05). No differences in basal levels of superoxide anion were evident in the two cell types (p = 0.34), possibly because of increased SOD in lysates of CHO-OR cells compared to CHO-WT cells (data not shown). Whereas only a relatively small increase in the production of hydroxyl radicals and superoxide anion was noted in CHO-WT cells treated with nitrofurantoin, CHO-OR cells produced significantly greater amounts of these ROI (p < 0.05, Figs. 5C and 5D). As observed with recombinant cytochrome P450 reductase, hydroxyl radical formation in these cells was dependent on iron and prevented by catalase and DMSO (p < 0.05 for both CHO-WT and CHO-OR cells) (Fig. 5C ). Moreover, SOD inhibited superoxide anion production in the cells (p < 0.05; Fig. 5D ).
Cytochrome P450 reductase and redox cycling of nitrofurantoin in different cell types
We next determined whether nitrofurantoin-induced H 2 O 2 generation was correlated with cytochrome P450 reductase activity in various cell types. These results are shown in Table 3 . A mouse-lung-derived epithelial cell line, MLE 15, was found to contain the highest NADPH-cytochrome c reductase activity and a human prostate cell line, PC-3, exhibited the lowest activity (17.5 ± 1.0 units/mg protein vs 2.5 ± 0.4 units/mg protein, respectively). Table 1 (Table 2) .
Interestingly, in all of the cell lines except HT-29 cells, redox cycling of nitrofurantoin was found to directly correlate with cytochrome P450 reductase activity (Fig. 6, top) . In HT-29 cells, significantly more nitrofurantoin redox activity was detected relative to cytochrome P450 reductase activity. Because cytochrome P450 reductase is a microsomal enzyme [24, 25] , we next analyzed nitrofurantoin redox cycling in microsomal and cytosolic fractions of HT-29 cells. For comparison, we also analyzed MLE 15 cells. As expected, in MLE 15 cells, the majority of nitrofurantoin-stimulated H 2 O 2 generation appeared in the microsomal fraction of the cells (p = 0.001) ( Table 4 ). In contrast, the cytosolic fraction of HT-29 cells contained significantly more nitrofurantoin-stimulated H 2 O 2 generation activity than the microsomal fraction (p = 0.005). These data indicate that HT-29 cells contain high activity of additional NADPH oxidoreductases in the cytosolic fraction capable of redox cycling nitrofurantoin.
Effects of nitrofurantoin on intracellular ROI production and cell growth inhibition
Because cell lysates were found to redox cycle nitrofurantoin, we next determined whether this was associated with ROI production in intact cells. For these studies we used techniques in flow cytometry in conjunction with the ROI-sensitive probe, DCFH-DA, to evaluate intracellular H 2 O 2 production. We found that nitrofurantoin readily induced H 2 O 2 in intact CHO cells. In CHO-WT cells, nitrofurantoin increased intracellular H 2 O 2 production approximately 7-fold (p < 0.001; Fig. 7, left) . In contrast, in CHO-OR cells, nitrofurantoin was significantly more effective in increasing intracellular H 2 O 2 production. Thus, after nitrofurantoin treatment, a subpopulation of extremely bright CHO-OR cells (approximately 75% of the total number of cells analyzed) increased H 2 O 2 production approximately 60-fold (p = 0.0016; Fig. 7, right) . The remaining cells in a less bright subpopulation also increased H 2 O 2 production approximately 5-fold (p < 0.001). At the present time, the origin of the subpopulation heterogeneity in CHO-OR cells with respect to H 2 O 2 production is not known. However, these data are consistent with the increased abililty of CHO-OR cells to redox cycle nitrofurantoin. Interestingly, despite marked differences in nitrofurantoininduced redox cycling and intracellular H 2 O 2 production in CHO-WT and CHO-OR cells, their responses to nitrofurantoin-induced cytotoxicity, as measured by growth inhibition, were similar (IC 50 = 53 ± 1 μM vs 42 ± 3 μM for CHO-WT and CHO-OR cells, respectively) (Fig. 8, left and Table 3 ). We also found that the different cell types varied approximately 5-to 6-fold in their sensitivity to nitrofurantoin-induced growth inhibition (IC 50 = 14-80 μM). Moreover, no correlation was observed between nitrofurantoin redox cycling and growth inhibition (Fig. 6, bottom) . For example, although similar cytochrome P450 reductase activity was detected in C2 and S-180 cells (6.1 ± 0.2 units/mg protein vs 7.4 ± 1.0 units/mg protein; p > 0.05) and the ability of the two cell types to redox cycle nitrofurantoin was similar (V max = 3.5 ± 0.2 nmol H 2 O 2 /mg protein/min vs 4.4 ± 0.3 nmol H 2 O 2 /mg protein/min for C2 and S-180 cells, respectively; p > 0.05), S-180 cells were significantly more sensitive to nitrofurantoin-induced cytotoxicity (p < 0.05, Fig. 8 , right and Table 3 ). Furthermore, PC-3 cells, which display significantly less nitrofurantoin-induced redox cycling activity than MLE 15 (p < 0.001) or HT-29 cells (p < 0.05), were 2-to 3-fold more sensitive to nitrofurantoin-induced growth inhibition (p < 0.001 comparing PC-3 with MLE 15 cells and p < 0.01 comparing PC-3 with HT-29 cells; compare Tables 1 and 3 ).
Discussion
Several enzymes in mammalian cells that mediate one-electron reduction of nitroaromatic compounds to reactive electrophilic intermediates have been identified including cytochrome P450 reductase [14, 26] , NADH:lipoamide oxidoreductase [27] , NAD(P)H:quinone oxidoreductase (NQO1) [28] , thioredoxin reductase [29] , nitric oxide synthase [30] , xanthine oxidase [31] , and ferredoxin: NADP + reductase [32] . Oxidation of reactive electrophilic intermediates back to the parent compound generates toxic ROI. It is well recognized that nitrofurantoin can undergo a one-electron reduction; however, the enzymatic activity mediating this reaction is not well characterized. Previous studies have demonstrated that microsomal fractions from rat lung and liver can reduce nitrofurantoin, suggesting that this process is mediated by cytochrome P450 reductase [33] . This is supported by the observation that inhibitors of this enzyme suppress reduction of nitrofurantoin in rat hepatocytes [14] . Using purified rat liver cytochrome P450 reductase, it has also been demonstrated that nitrofurantoin undergoes a one-electron reduction to the nitro aromatic anion radical and is reoxidized under aerobic condition [34] . Our data show that redox cycling of nitrofurantoin by a recombinant cytochrome P450 reductase, or lysates from a variety of cell types, generates superoxide anion, hydrogen peroxide, and, in the presence of redox-active iron, hydroxyl radicals. This redox cycling reaction requires NADPH and is inhibited by diphenyleneiodonium, demonstrating that it is dependent on the flavin cofactors in the cytochrome P450 reductase.
ROI are known to be cytotoxic and their production during nitrofurantoin redox cycling has the potential to contribute to tissue injury. To examine the relationship between nitrofurantoin-induced ROI production during redox cycling and cytotoxicity, we used cell lines varying in their cytochrome P450 reductase activity. We found that there was a direct correlation between the nitrofurantoin redox cycling and the activity of cytochrome P450 reductase in the cells. This was most evident in CHO cells constructed to overexpress cytochrome P450 reductase in which nitrofurantoin redox cycling was more than 15 times greater than that in wild-type cells. The overexpressing cells also produced approximately six-fold more intracellular ROI following nitrofurantoin treatment. Unexpectedly, no major differences between the two cell types with respect to nitrofurantoin-induced cytotoxicity as measured by growth inhibition were evident. These data suggest that cytotoxicity is independent of nitrofurantoin redox cycling and ROI production. This is supported by similar findings in several cell lines. For example, S-180 cells were two times more sensitive to growth inhibition by nitrofurantoin than C2 cells, despite that the cells displayed similar nitrofurantoin redox cycling activity. Furthermore, although MLE 15 cells displayed approximately four-fold more nitrofurantoin redox cycling activity than PC-3 cells, they were three-fold less sensitive to nitrofurantoin-induced cytotoxicity. These data provide support for the idea that nitrofurantoin redox cycling and subsequent production of ROI does not mediate cytotoxicity. Thus, levels of cytochrome P450 reductase activity in tumor cells may not be predictive for a higher level of sensitivity against nitrofurantoin toxicity.
At the present time, the mechanisms underlying nitrofurantoin toxicity is not known. Among the ROI generated during nitrofurantoin-induced redox cycling, hydroxyl radicals are the most damaging [35, 36] . Cytotoxicity may, in part, be related to the ability of nitrofurantoin to generate hydroxyl radicals in each cell line, a process that depends on the availability of redox-active metals such as iron and copper. It is possible that the different cell lines vary in their metal content and that this limits nitrofurantoin-induced cytotoxicity. In this regard, Staubli and Boelsterli [37] and Sturm et al. [38] reported that nitrofurantoin increases the intracellular labile iron pool, a factor that may control redox cycling. Alternatively, intracellular levels of antioxidants that detoxify and protect against ROI-induced damage may be important in regulating nitrofurantoin-induced cytotoxicity. In this regard, superoxide dismutase, catalase, and antioxidants including alpha-tocopherol, ascorbic acid, and dimethyl sulfoxide have been reported to block nitrofurantoin-induced cytotoxicity in a rat lung explant model [8] . Metabolism of nitrofurantoin to reactive metabolites is another factor that may regulate cytotoxicity. Electrophilic intermediates formed as a result of redox cycling of nitrofurantoin have been reported to bind glutathione and cellular macromolecules [33] . The generation of these metabolites depends on localized oxygen tension which can control bioreduction of nitrofurantoin in target tissues [10] . Reduction of nitrofurantoin to its amine and further derivatization may also generate cytotoxic metabolites [34, 39] . Additional studies are needed to characterize metabolism of nitrofurantoin in the various cell types under different conditions and to determine its role in cytotoxicity.
Although redox cycling of nitrofurantoin is directly correlated with cytochrome P450 reductase activity in almost all the cell lines, it is likely that additional oxidoreductases in the cells redox cycle this antibiotic. This is supported by our findings of significant nitrofurantoin redox cycling in the cytosol of HT-29 cells which does not contain cytochrome P450 reductase activity. Low levels of nitrofurantoin redox cycling activity were also evident in cytosolic fractions of MLE 15 cells, suggesting that additional enzymes also redox cycle nitrofurantoin in these cells. In this regard, our laboratory has recently demonstrated paraquat redox cycling by thioredoxin reductase in cytosolic fractions of MLE 15 cells [40] . Studies to identify the NADPH oxidoreductases that are important in redox cycling nitrofurantoin in the cytosolic fraction of cells are in progress. It should be noted that we also cannot exclude the possibility that, in addition to cytochrome P450 reductase, other oxidoreductases mediate redox cycling of nitrofurantoin in the microsomal fraction of cells.
Using recombinant cytochrome P450 reductase, we found that increased nitrofurantoin redox cycling was due to an increase in V max for NADPH with little change in affinity of the enzyme for the pyridine nucleotide. Moreover, in all cell types except RAW 264.7 and B16 cells, nitrofurantoin redox cycling increased the V max but appeared to decrease the enzyme affinity for NADPH. The changes in reaction kinetics for NADPH in RAW 264.7 and B16 cells were similar to the recombinant cytochrome P450 reductase. Increases in V max were not surprising because we are measuring redox cycling in nitrofurantoin-sensitive redox enzymes. However, apparent changes in affinity of NADPH in enzyme assays are most likely due to differences in the kinetic characteristics of various constitutive enzymes in cell lysates that utilize NADPH as a one-electron donor for redox cycling in the absence of nitrofurantoin and the specific characteristics of the enzyme(s) activated by the drug. The mechanisms underlying the distinct reaction kinetics for NADPH in RAW 264.7 and B16 cells are not apparent. It will be of interest to characterize the enzymes in these and the other cell lines that are important in nitrofurantoin redox cycling.
In summary, our data show that nitrofurantoin readily redox cycles with recombinant cytochrome P450 reductase and lysates of many different cell types. In the cells, ROI generated by nitrofurantoin redox cycling directly correlates with cytochrome P450 reductase activity. However, it does not correlate with the cytotoxicity of nitrofurantoin. Thus, in these cells, ROI-induced oxidative stress alone does not mediate the toxicity of nitrofurantoin. In humans and other animals, nitrofurantoin is known to induce toxicity in many tissues including lung, liver, peripheral nerves and blood. Further studies to determine the role of redox cycling in nitrofurantoin-induced toxicity in these tissues and to identify alternative sites of action of this drug in tumor cells are needed. In the presence of oxygen, the radical disproportionates to form superoxide anion and the parent compound. Adapted from Minchin et al. [10] . (A) Nitrofurantoin-induced H 2 O 2 production. Enzyme reactions were run in absence or presence of increasing concentrations of nitrofurantoin. Accumulation of H 2 O 2 in the assay mixes was quantified using the Amplex red/horseradish peroxidase reaction (n = 3 ± SE). (B and C) Nitrofurantoin-induced hydroxyl radical and superoxide production. Reactions were run in the absence or presence of 25 or 100 μM NFT. Hydroxyl radicals in enzyme assays were quantified by the formation of 2-hydroxyterephthalate (2-OH TPT) derived from terephthalate (n = 2 ± SD). In some assays, catalase (400 U/ml) or DMSO (70 mM) was added to prevent hydroxyl radical formation. Note that the generation of hydroxyl radicals was dependent on the presence of redox-active iron. Superoxide in the enzyme assays was quantified as the formation of 2-hydroxyethidium derived from dihydroethidium. In some of the assays, SOD (350 U/ml) was added to inhibit superoxide formation. C shows HPLC tracings of 2-hydroxyethidium formation. One of two representative experiments is shown. All enzyme reaction mixes contained 0.5 mM NADPH. ** p < 0.01 compared to rat P450 OR without NFT, # p < 0.05 and ## p < 0.01 compared to rat P450 OR with 100 μM NFT. Reaction mixes containing 0.1 mM NADPH were analyzed in 1-ml spectrophotometer cuvettes. Absorbance spectra were recorded at 2.5-min intervals. (Top) Nitrofurantoinstimulated NADPH depletion; 50 μM nitrofurantoin was added directly to the cuvette. (Bottom) NADPH metabolism in the enzyme assay in the absence of nitrofurantoin. Hydroxyl radicals in enzyme assays were quantified by the formation of 2-hydroxyterephthalate (2-OH TPT) (n = 2 ± SD). In some assays, catalase (400 U/ml) or DMSO (70 mM) was added to prevent hydroxyl radical formation. Superoxide in the enzyme assays was quantified by the formation of 2-hydroxyethidium from dihydroethidium. In some of the assays, SOD (350 U/ml) was added to prevent superoxide formation. D shows HPLC tracings of 2-hydroxyethidium formation. One of two representative experiments is shown. * p < 0.05 and *** p < 0.001 comparing CHO-WT with CHO-OR cells. (Top) Correlation between cellular cytochrome P450 reductase activity and nitrofurantoininduced H 2 O 2 production. Cytochrome P450 reductase activity was measured using a cytochrome c reduction assay. The V max for nitrofurantoin-induced H 2 O 2 generation (Table   1 ) was used to compare nitrofurantoin-induced redox cycling with cellular cytochrome P450 reductase activity. The inset shows the same data with CHO-OR cells omitted. Note the positive correlation between cytochrome P450 reductase activity and nitrofurantoin-induced redox cycling. (Bottom) Lack of correlation between nitrofurantoin-induced redox cycling and cellular cytotoxicity. Redox cycling capacity of the cell lines was plotted against the concentration of nitrofurantoin inhibiting growth by 50% (IC 50 ) in each cell line (Table 3) . 
